Low, High Sodium in ESKD Increases In-Hospital Death Risk, Hospital Stays
Hyper- and hyponatremia in patients with kidney failure are significantly associated with a 2.0- and 1.8-fold increased risk of dying in the hospital, respectively.
Hyper- and hyponatremia in patients with kidney failure are significantly associated with a 2.0- and 1.8-fold increased risk of dying in the hospital, respectively.
Hyponatremia and hypernatremia in patients hospitalized for COVID-19 are associated with increased odds of adverse outcomes.
Nearly 52% of adult patients hospitalized for COVID-19 in the metropolitan New York region had hyponatremia or hypernatremia at admission, a study found.
Both high and low serum sodium levels relative to an optimal range at hospital discharge are associated with an increased 1-year mortality risk.
The patient noted that she was initiated on naproxen by her primary care physician 2 weeks prior to her presentation.
Each level of worsening hyponatremia among patients hospitalized with COVID-19 was significantly associated with 43% increased odds of dying in the hospital, a study found.
In an observational study, furosemide doses of 250 to 500 mg and spironolactone doses of 50 to 100 mg were independently associated with approximately 14% and 20% increased odds of hyponatremia, respectively.
Adding furosemide with or without sodium chloride to fluid restriction is not more effective than fluid restriction alone at correcting hyponatremia in patients with the syndrome of inappropriate antidiuresis, a study found.
In a study, users of the older formulation of desmopressin had a 13-fold higher rate of hyponatremia than users of oxybutynin.
Among CKD patients older than 60 years, chronic prolonged hyponatremia is associated with 36% increased odds of hip fracture in adjusted analyses, a study found.